苏州市姑苏区2013—2022年女性乳腺癌发病情况和减寿分析

张秋, 徐焱, 吴新凡, 肖知明

安徽预防医学杂志 ›› 2025, Vol. 31 ›› Issue (1) : 63-67.

PDF(828 KB)
PDF(828 KB)
安徽预防医学杂志 ›› 2025, Vol. 31 ›› Issue (1) : 63-67. DOI: 10.19837/j.cnki.ahyf.2025.01.013
疾病控制

苏州市姑苏区2013—2022年女性乳腺癌发病情况和减寿分析

作者信息 +

Incidence and life loss analysis of female breast cancer in Gusu District of Suzhou City from 2013 to 2022

Author information +
文章历史 +

摘要

目的 分析苏州市姑苏区2013—2022年女性乳腺癌的流行特征与减寿情况,为辖区乳腺癌的预防与控制提供科学依据。方法 从苏州市疾病监测信息系统和江苏省慢性病管理信息平台分别下载2013—2022年姑苏区女性乳腺癌的发病和死亡病例信息,计算发病率、死亡率、潜在减寿年数(YPLL)、标化潜在减寿年数(SYPLL)、潜在减寿率(YPLLR)、标化潜在减寿率(SYPLLR)、平均减寿年数(AYLL)等指标,采用Joinpoint 4.9.1.0软件计算平均年度变化百分比(AAPC)。结果 2013—2022年姑苏区报告女性乳腺癌2 980例,发病率为78.68/10万,中国人口标化发病率为58.02/10万;女性乳腺癌死亡618例,死亡率为16.32/10万,中国人口标化死亡率为8.92/10万。2013—2022年姑苏区女性乳腺癌发病率在73.47/10万~81.51/10万(AAPC=0.560%,t=0.388,P=0.708)之间波动,死亡率在13.69/10万~17.60/10万(AAPC=0.582%,t=0.483,P=0.642)之间波动,差异均无统计学意义。年龄别发病率和死亡率数据显示,姑苏区60~64岁女性乳腺癌发病率最高(142.38/10万),85岁及以上女性乳腺癌死亡率最高(92.03/10万)。潜在减寿分析结果显示,2013—2022年姑苏区女性乳腺癌YPLL为4 375.00人年,SYPLL为3 474.24人年,YPLLR为1.36‰,SYPLLR为1.08‰,AYLL为13.02年/人。结论 姑苏区女性乳腺癌的发病率和死亡率较高,老年女性是姑苏区乳腺癌防治的重点人群。

Abstract

Objective To analyze the epidemic characteristics and life loss of female breast cancer in Gusu District of Suzhou City from 2013 to 2022,and provide scientific basis for the prevention and control of breast cancer in this area. Methods Data was downloaded on the incidence and death of female breast cancer in Gusu District from 2013 to 2022 from Suzhou Disease Surveillance Information System the Chronic Disease Management Information Platform of Jiangsu Province,calculate the incidence rate,mortality,potential years of life lost (YPLL),standardized potential years of life lost (SYPLL),potential life lost rate (YPLLR),standardized potential life lost rate (SYPLLR),average years of life lost (AYLL) and other indicators.Use the Joinpoint 4.9.1.0 software to calculate the average annual change percentage (AAPC). Results From 2013 to 2022,there were 2 980 cases of female breast cancer reported in Gusu District,with an incidence rate of 78.68/100 000,and the age-standardized incidence rate by Chinese standard population (ASIRC) was 58.02/100 000.618 women died of breast cancer,with a mortality rate of 16.32/100 000,and the age-standardized mortality rate by Chinese standard population (ASMRC) was 8.92/100 000.From 2013 to 2022,the incidence rate of female breast cancer in Gusu District fluctuated between 73.47/100 000 and 81.51/100 000 (AAPC=0.560%,t=0.388,P=0.708),and the mortality rate between 13.69/100 000 and 17.60/100 000 (AAPC=0.582%,t=0.483,P=0.642),with no statistical significance.The age specific incidence rate and mortality rate showed that the incidence rate of breast cancer among women aged 60 to 64 in Gusu District was the highest,142.38/100 000,and the mortality of breast cancer among women aged 85 and above was the highest,92.03/100 000.The analysis results of potential life loss showed that from 2013 to 2022,the YPLL of female breast cancer in Gusu District was 4 375.00 person years,the SYPLL was 3 474.24 person years,the YPLLR was 1.36‰,the SYPLLR was 1.08‰,and the AYLL was 13.02 years/person. Conclusion The incidence and mortality rates of breast cancer among women in Gusu District are relatively high,and the elderly women are the key population for prevention and treatment of breast cancer in Gusu District.

关键词

乳腺癌 / 发病 / 死亡 / 流行特征 / 寿命损失 / 女性

Key words

Breast cancer / Morbidity / Mortality / Epidemiological characteristics / Life loss / Women

引用本文

导出引用
张秋, 徐焱, 吴新凡, . 苏州市姑苏区2013—2022年女性乳腺癌发病情况和减寿分析[J]. 安徽预防医学杂志. 2025, 31(1): 63-67 https://doi.org/10.19837/j.cnki.ahyf.2025.01.013
ZHANG Qiu, XU Yan, WU Xinfan, et al. Incidence and life loss analysis of female breast cancer in Gusu District of Suzhou City from 2013 to 2022[J]. Anhui Journal of Preventive Medicine. 2025, 31(1): 63-67 https://doi.org/10.19837/j.cnki.ahyf.2025.01.013
中图分类号: R195.4   

参考文献

[1]
师金, 梁迪, 李道娟, 等. 全球女性乳腺癌流行情况研究[J]. 中国肿瘤, 2017, 26(9):683-690.
[2]
马青, 吴小玲, 方丹丹. 乳腺癌患者保乳手术术后无病生存期状况及其影响因素[J]. 浙江创伤外科, 2024, 29(2):315-317.
[3]
徐国荣, 王耐, 潘美玉. 40068例女性乳腺彩超检查结果分析[J]. 安徽预防医学杂志, 2022, 28(2):135-137.
[4]
郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1):19-28.
[5]
朱宝立, 周金意, 韩仁强, 等. 江苏省恶行肿瘤报告[M](2021). 南京: 东南大学出版社, 2023:1-210.
[6]
黄育北, 佟仲生, 陈可欣, 等. 《中国女性乳腺癌筛查指南》解读(精简版)[J]. 中国肿瘤临床, 2019, 46(9):432-440.
[7]
戴丹, 徐伟, 贺琴, 等. 安徽省2010—2018年肿瘤登记地区胃癌发病趋势分析[J]. 安徽预防医学杂志, 2023, 29(4):267-270+283.
[8]
闫云燕, 常颖, 秦延锦. 2012—2018年洛阳市女性乳腺癌发病死亡特征分析[J]. 实用预防医学, 2022, 29(10):1210-1214.
[9]
王馨, 丁高恒, 王宏宗, 等. 2009—2015年甘肃省肿瘤登记地区乳腺癌流行特征及变化趋势分析[J]. 中国癌症防治杂志, 2022, 14(1):99-104.
[10]
林菲, 王倩, 朱晓云. 2002—2015年上海市金山区女性乳腺癌发病和死亡趋势分析[J]. 中国肿瘤, 2021, 30(4):268-273.
[11]
崔俊鹏, 陆艳, 黄春妍, 等. 2007—2021年苏州市女性乳腺癌死亡与减寿分析[J]. 预防医学, 2023, 35(5):380-383.
[12]
高瑜璋, 孔芳芳, 乔莹. 2008—2012年苏州市某区女性乳腺癌发病及死亡情况[J]. 职业与健康, 2014, 30(2):255-257.
[13]
李爱娟, 欧孟言, 许燕君, 等. 2017年广东省肿瘤登记地区女性乳腺癌流行特征及2013—2017年变化趋势[J]. 中国肿瘤, 2024, 33(1):62-67.
[14]
刘雪薇, 王媛, 韦丹梅, 等. 1990—2019年中国女性乳腺癌发病及死亡趋势的年龄-时期-队列模型分析[J]. 中国全科医学, 2023, 26(1):34-41.
[15]
苏彦萍, 吴芹, 孙晓伟, 等. 2005—2020年北京市通州区女性乳腺癌及生殖系统主要恶性肿瘤死亡趋势分析[J]. 职业与健康, 2022, 38(22):3066-3071.
[16]
蒲星月, 马原, 钟志刚. 2006—2020年中国女性乳腺癌死亡趋势分析——基于年龄-时期-出生队列模型[J]. 卫生经济研究, 2023, 40(2):28-33.
[17]
王莹, 马霞, 宫舒萍, 等. 2011—2021年山东省济南市女性乳腺癌死亡趋势分析[J]. 中国肿瘤, 2023, 32(10):766-772.
[18]
徐志坚, 刘炬, 陈万青, 等. 乳腺癌机会性筛查规范路径专家共识[J]. 中国肿瘤, 2024, 33(1):6-18.
[19]
Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO 4th international consensus guidelines for breast cancer in young women (BCY4)[J]. Ann Oncol, 2020, 31(6):674-696.
The 4th International Consensus Conference for Breast Cancer in Young Women (BCY4) took place in October 2018, in Lugano, Switzerland, organized by the European School of Oncology (ESO) and the European Society of Medical Oncology (ESMO). Consensus recommendations for the management of breast cancer in young women were updated from BCY3 with incorporation of new evidence to inform the guidelines. Areas of research priorities were also identified. This article summarizes the ESO-ESMO international consensus recommendations, which are also endorsed by the European Society of Breast Specialists (EUSOMA).Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.
[20]
陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床, 2015, 42(13):668-674.
[21]
张雪, 董晓平, 管雅喆, 等. 女性乳腺癌流行病学趋势及危险因素研究进展[J]. 肿瘤防治研究, 2021, 48(1):87-92.

基金

姑苏卫生人才培养项目(GSWS2019091)

PDF(828 KB)

Accesses

Citation

Detail

段落导航
相关文章

/